
B. Riley Securities Reaffirms Their Buy Rating on LifeMD (LFMD)

I'm PortAI, I can summarize articles.
B. Riley Securities has reiterated its Buy rating on LifeMD with a price target of $10.00. Additionally, Lake Street's Ryan Meyers also issued a Buy rating, while TR | OpenAI maintained a Hold rating on LifeMD.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

